Skip to main content

Prototype Prescribing Outlier Dashboard for Millgate Healthcare Partnership

At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at [email protected]. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system, the count of all prescriptions within that chemical's BNF subparagraph, for prescriptions dispensed between June 2021 and December 2021. We then calculate the ratio of these counts along with the mean and standard deviation of those ratios across all Practices. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given Practice is from the population mean. We then rank your “z-scores” to find the top 10 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

For each outlier chemical, a kernel density estimation plot of all Practice's chemical:subparagraph ratios is provided, with this Practice's ratio overlaid in red.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not, to inform research on this topic. Our full analytical method code is openly available on GitHub here.

This is a new, experimental feature. We'd love to .

Prescribing where Millgate Healthcare Partnership is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Fluphenazine decanoate 1 Antipsychotic depot injections 1 1.00 0.00 0.06 17.40
Insulin glargine/lixisenatide 8 Intermediate and long-acting insulins 1,130 0.01 0.00 0.00 4.92
Nefopam hydrochloride 901 Non-opioid analgesics and compound preparations 10,782 0.08 0.01 0.02 4.20
Prednisolone sodium phosphate 65 Corticosteroids 156 0.42 0.07 0.10 3.50
Valsartan 372 Angiotensin-II receptor antagonists 4,784 0.08 0.02 0.02 3.18
Travoprost 285 Treatment of glaucoma 2,124 0.13 0.04 0.03 3.12
Timolol 286 Treatment of glaucoma 2,124 0.13 0.06 0.03 2.40
Ferric maltol 26 Oral iron 2,758 0.01 0.00 0.00 2.37
Canagliflozin 868 Other antidiabetic drugs 4,487 0.19 0.05 0.06 2.29
Trospium chloride 325 Drugs for urinary frequency enuresis and incontinence 2,538 0.13 0.04 0.04 2.13

Prescribing where Millgate Healthcare Partnership is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Trimethoprim 148 Sulfonamides and trimethoprim 236 0.63 0.87 0.12 -1.98
Prucalopride 17 Other drugs used in constipation 98 0.17 0.71 0.32 -1.66
Tacrolimus 0 Corticosteroids and other immunosuppressants 8 0.00 0.63 0.40 -1.58
    Timolol and bimatoprost 43 Treatment of glaucoma 2,124 0.02 0.10 0.05 -1.55
    Dexamethasone 25 Corticosteroids 156 0.16 0.49 0.22 -1.47
    Co-amoxiclav (Amoxicillin/clavulanic acid) 119 Broad-spectrum penicillins 1,864 0.06 0.15 0.07 -1.22
    Mometasone furoate 56 Topical corticosteroids 2,548 0.02 0.07 0.04 -1.20
    Olanzapine 333 Antipsychotic drugs 2,811 0.12 0.22 0.09 -1.19
    Co-careldopa (Carbidopa/levodopa) 125 Dopaminergic drugs used in parkinsonism 1,100 0.11 0.33 0.18 -1.17
    Empagliflozin 146 Other antidiabetic drugs 4,487 0.03 0.15 0.10 -1.15